Drug Trial Radar · NCT03535298
Determining the Effectiveness of earLy Intensive Versus Escalation Approaches for RRMS
Last checked: Nov 19, 2026Latest source record: Aug 31, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
800
Planned (sponsor's estimate)
Start
Jan 3, 2019
Primary completion
Jul 30, 2027
Study completion Jul 30, 2027
Sponsor
- Lead sponsor
- The Cleveland ClinicAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- University of Nottingham
- First posted
- May 24, 2018
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 60 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The DELIVER-MS study seeks to answer the question: Does early treatment with highly effective DMT improve the prognosis for people with MS? This is an area of significant controversy and no data currently exist to guide treatment choices for patients and clinicians. The study results will help guide overall treatment philosophy and will be applicable not only to a wide range of existing therapies but also to new therapies, meeting a significant unmet need in patient decision making and aiding the decision for medication approval by third parties.
Conditions
- Multiple Sclerosis, Relapsing-Remitting
Interventions
Early Highly Effective Therapies GroupDrug
Highly Effective MS Therapy group of medications
Escalation Therapies GroupDrug
Escalation MS Therapy group of medications
Primary outcomes
What the sponsor says the trial is designed to measure.
- Brain volume loss, baseline to month 36Time frame: Baseline to 36 months
- EDSS+, month 48 to month 108Time frame: 48 months to 108 months
Locations
30 sites in 2 countries. Site status is shown where the registry gives one.
University of Colorado-Anschutz Medical Campus
Aurora, Colorado
University of Minnesota
Minneapolis, Minnesota
Mayo Clinic
Rochester, Minnesota
Cleveland Clinic Lou Ruvo Center for Brain Health
Las Vegas, Nevada
University of Buffalo
Buffalo, New York
University Rochester Medical Center
Rochester, New York
University of Cincinnati
Cincinnati, Ohio
Cleveland Clinic
Cleveland, Ohio
Ohio Health
Columbus, Ohio
UT-Austin
Austin, Texas
Baylor College of Medicine, Houston
Houston, Texas
UTHealth-Houston
Houston, Texas
University of Virginia
Charlottesville, Virginia
Virginia Commonwealth University
Richmond, Virginia
University of Wisconsin-Madison
Madison, Wisconsin
Nottingham University Hospitals NHS Trust, Queens Medical Centre
Nottingham, United Kingdom
University Hospitals Coventry and Warwickshire
Coventry, England, United Kingdom
The Leeds Teaching Hospitals NHS Trust, Leeds General Infirmary
Leeds, England, United Kingdom
University Hospitals Leicester
Leicester, England, United Kingdom
Imperial College Healthcare NHS Trust, Charing Cross Hospital
London, England, United Kingdom
University College London Hospitals NHS Foundation Trust, University College Hospital
London, England, United Kingdom
Salford Royal NHS Foundation Trust, Salford Hospital
Manchester, England, United Kingdom
Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital
Oxford, England, United Kingdom
University Hospitals Plymouth NHS Trust, Derriford Hospital
Plymouth, England, United Kingdom
Sheffield Teaching Hospitals
Sheffield, England, United Kingdom
University Hospitals of North Midlands
Stoke, England, United Kingdom
Royal Infirmary of Edinburgh
Edinburgh, Scotland, United Kingdom
Cardiff and Vale University Local Health Board, University Hospital of Wales
Cardiff, Wales, United Kingdom
Aneurin Bevan Local Health Board Headquarters, Royal Gwent Hospital
Newport, Wales, United Kingdom
Swansea Bay University Local Health Board, Morriston Hospital
Swansea, Wales, United Kingdom
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.